Welcome: HANGZHOU HONGQIN PHARMTECH CO.,LTD
Language: Chinese   English

Home > Products > peptides > Retatrutide

Retatrutide

Glp-1 receptor activation: Inhibits appetite, delays gastric emptying; Glucose-dependent insulin secretion is promoted to lower blood sugar and HbA1c.

2. GIP (glucose-dependent insulin-stimulating polypeptide) receptor activation: Enhances the weight loss effect of GLP-1, further inhibits food intake, and protects β -cell function.
3. GCGR (glucagon receptor) activation: Enhances energy expenditure, promotes fat breakdown, and reduces visceral fat; Improve fat accumulation in the liver.
In a nutshell: reducing intake, enhancing satiety, and increasing energy expenditure - the intensity of weight loss is currently among the top tier of peptide drugs
PREVIOUS:Survodutide NEXT:Abaloparatide

Products Category

CONTACT US

Name: IDA ZHANG

Mobile:0086 13675855990

Tel:0086 571-87803090

Email:info@hqpharmtech.cn

Add:702, Building 2, No. 15 Jiuzhou Road, Shangcheng District, Hangzhou City, Zhejiang Province


Top footer
Contact us Close

Company: HANGZHOU HONGQIN PHARMTECH CO.,LTD

Contact: IDA ZHANG

Tel: 0086 571-87803090

Phone: 0086 13675855990

E-mail: info@hqpharmtech.cn

Address: 702, Building 2, No. 15 Jiuzhou Road, Shangcheng District, Hangzhou City, Zhejiang Province

Scan the qr code Close
Qr code